Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 115

1.

Comparison of the immunological responses and efficacy of gamma-irradiated V3526 vaccine formulations against subcutaneous and aerosol challenge with Venezuelan equine encephalitis virus subtype IAB.

Martin SS, Bakken RR, Lind CM, Garcia P, Jenkins E, Glass PJ, Parker MD, Hart MK, Fine DL.

Vaccine. 2010 Jan 22;28(4):1031-40. doi: 10.1016/j.vaccine.2009.10.126. Epub 2009 Nov 13.

2.

Evaluation of formalin inactivated V3526 virus with adjuvant as a next generation vaccine candidate for Venezuelan equine encephalitis virus.

Martin SS, Bakken RR, Lind CM, Garcia P, Jenkins E, Glass PJ, Parker MD, Hart MK, Fine DL.

Vaccine. 2010 Apr 19;28(18):3143-51. doi: 10.1016/j.vaccine.2010.02.056. Epub 2010 Mar 1.

3.

A multisystem approach for development and evaluation of inactivated vaccines for Venezuelan equine encephalitis virus (VEEV).

Fine DL, Jenkins E, Martin SS, Glass P, Parker MD, Grimm B.

J Virol Methods. 2010 Feb;163(2):424-32. doi: 10.1016/j.jviromet.2009.11.006. Epub 2009 Nov 10.

4.

Venezuelan equine encephalitis virus vaccine candidate (V3526) safety, immunogenicity and efficacy in horses.

Fine DL, Roberts BA, Teehee ML, Terpening SJ, Kelly CL, Raetz JL, Baker DC, Powers AM, Bowen RA.

Vaccine. 2007 Feb 26;25(10):1868-76. Epub 2006 Oct 27.

PMID:
17240002
5.

Induction of protective immune responses against Venezuelan equine encephalitis (VEE) virus aerosol challenge with microencapsulated VEE virus vaccine.

Greenway TE, Eldridge JH, Ludwig G, Staas JK, Smith JF, Gilley RM, Michalek SM.

Vaccine. 1998 Aug;16(13):1314-23.

PMID:
9682396
6.

A DNA vaccine for venezuelan equine encephalitis virus delivered by intramuscular electroporation elicits high levels of neutralizing antibodies in multiple animal models and provides protective immunity to mice and nonhuman primates.

Dupuy LC, Richards MJ, Ellefsen B, Chau L, Luxembourg A, Hannaman D, Livingston BD, Schmaljohn CS.

Clin Vaccine Immunol. 2011 May;18(5):707-16. doi: 10.1128/CVI.00030-11. Epub 2011 Mar 30.

7.
8.

CpG used as an adjuvant for an adenovirus-based Venezuelan equine encephalitis virus vaccine increases the immune response to the vector, but not to the transgene product.

Perkins SD, Williams AJ, O'Brien LM, Laws TR, Phillpotts RJ.

Viral Immunol. 2008 Dec;21(4):451-7. doi: 10.1089/vim.2008.0052.

PMID:
19115934
9.
10.

Safety and protective efficacy of INA-inactivated Venezuelan equine encephalitis virus: implication in vaccine development.

Sharma A, Gupta P, Glass PJ, Parker MD, Maheshwari RK.

Vaccine. 2011 Jan 29;29(5):953-9. doi: 10.1016/j.vaccine.2010.11.033. Epub 2010 Nov 27.

PMID:
21115048
12.

Immunogenicity and protective efficacy of a DNA vaccine against Venezuelan equine encephalitis virus aerosol challenge in nonhuman primates.

Dupuy LC, Richards MJ, Reed DS, Schmaljohn CS.

Vaccine. 2010 Oct 28;28(46):7345-50. doi: 10.1016/j.vaccine.2010.09.005. Epub 2010 Sep 17.

PMID:
20851089
14.
15.

Improved mucosal protection against Venezuelan equine encephalitis virus is induced by the molecularly defined, live-attenuated V3526 vaccine candidate.

Hart MK, Caswell-Stephan K, Bakken R, Tammariello R, Pratt W, Davis N, Johnston RE, Smith J, Steele K.

Vaccine. 2000 Jul 1;18(26):3067-75.

PMID:
10825611
16.
17.

Enhancement of protective immune responses to Venezuelan equine encephalitis (VEE) virus with microencapsulated vaccine.

Greenway TE, Eldridge JH, Ludwig G, Staas JK, Smith JF, Gilley RM, Michalek SM.

Vaccine. 1995;13(15):1411-20.

PMID:
8578818
19.

Neurovirulence evaluation of Venezuelan equine encephalitis (VEE) vaccine candidate V3526 in nonhuman primates.

Fine DL, Roberts BA, Terpening SJ, Mott J, Vasconcelos D, House RV.

Vaccine. 2008 Jun 25;26(27-28):3497-506. doi: 10.1016/j.vaccine.2008.04.044. Epub 2008 May 7.

PMID:
18508163
20.

IRES-Containing VEEV Vaccine Protects Cynomolgus Macaques from IE Venezuelan Equine Encephalitis Virus Aerosol Challenge.

Rossi SL, Russell-Lodrigue KE, Killeen SZ, Wang E, Leal G, Bergren NA, Vinet-Oliphant H, Weaver SC, Roy CJ.

PLoS Negl Trop Dis. 2015 May 28;9(5):e0003797. doi: 10.1371/journal.pntd.0003797. eCollection 2015 May. Erratum in: PLoS Negl Trop Dis. 2015 Jun;9(6):e0003912.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk